Background
• Symptomatic atrial fibrillation (AF) occurs in at least 20% of patients with hypertrophic cardiomyopathy (HCM).
• HCM patients with paroxysmal AF have an increased risk of heart failure and embolic stroke.
• Asymptomatic AF is often detected at routine device follow-up, and indications for rhythm-control strategies and anticoagulation are not well-defined for this population.
• Burden and clinical significance created by asymptomatic and "silent" AF in HCM is unknown.
Minneapolis Heart Institute® at Abbott Northwestern Hospital Cardiovascular Grand Rounds 2/9/15
Methods
• We studied 288 consecutive HCM patients implanted with implantable cardioverterdefibrillators (ICD), mostly for primary prevention of sudden death.
• Intracardiac electrocardiograms (EGMs) were reviewed to document presence of AF.
• We compared the baseline characteristics and rates of stroke between patients with known and "silent" AF.
Results

